Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics

Abstract

The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer.

Keywords:

• Nanomedicine
• theranostics
• breast cancer
• ovarian cancer
• nanocarriers

Disclosure statement

The authors declare the research was conducted in the absence of any commercial relationship and there are no potential conflicts of interest.

Additional information

Funding

The authors acknowledge the financial support of the Brazilian National Council for Research and Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES) and the Foundation for Research Support of the State of Piauí (FAPEPI).